Cited by 236Sarcoma Diagnosis and TreatmentImmune cells in cancerCancer Immunotherapy and Biomarkers

The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.

The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma

Open access

Heymann, Marie-Françoise, Lézot, Frédéric, Heymann, Dominique·2019·Cellular Immunology

DOI 10.1016/j.cellimm.2017.10.011

Open this paper in CoChat — free account

Abstract

Osteosarcoma is a rare primary bone cancer characterized by cancer cells producing calcified osteoid extracellular matrix and inducing lung metastases with a high frequency. The local microenvironment defined several tumor niches controlling the tumor growth and cell extravasation. The immune infiltrate composes one of these niches. The immune environment of osteosarcoma is mainly composed by T-lymphocytes and macrophages but also contains other subpopulations including B-lymphocytes and mast cells. Osteosarcoma cells control the recruitment and differentiation of immune infiltrating cells and establish a local immune tolerant environment favorable to the tumor growth, drug resistance and the occurrence of metastases. Osteosarcoma cells are able to affect the balance between M1 and M2 macrophage subtypes and so could control the T-lymphocyte responses via the PD-1/PDL-1 system. In addition, mesenchymal stem cells may also contribute to this immune tolerance and strengthen the immune evasion. The present review gives a brief overview of the immune components of osteosarcoma and their most recent therapeutic interests.

Integrity signals

Registry

Crossref · 10.1016/j.cellimm.2017.10.011

Cites

124 of 124 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,338
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Clonal heterogeneity and tumor evolution: past, present, and the future
McGranahan, N., & Swanton, C. (2017) · Cell · doi:10.1016/j.cell.2017.01.018 · Cited by 2,840
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Distinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225
Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide
Ren, G., Zhang, L., Zhao, X., Xu, G., Zhang, Y., Roberts, A. I., Zhao, R. C., & Shi, Y. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2007.11.014 · Cited by 2,101
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
Takayanagi, H. (2007) · Nature Reviews Immunology · doi:10.1038/nri2062 · Cited by 1,878

Show all 125 references

Research works printed but not linked: 2

J. Kroner, A. Kovtun, J. Kemmler, J.J. Messmann, G. Strauss, S. Seitz, T. Schinke, M. Amling, J. Kotrba, J. Dudeck, A. Dudeck, A. Ignatius, Mast cellsare critical regulators ofbonefracture-induced inflammation and osteoclast formation and activity, J.BoneMiner. Res., in press.
M. Garcia-Moure, N. Martinez-Vélez, A. Patiño-García, M.M. Alonso, Oncolytic adnovirus as a therapeutic approach for osteosarcoma: a new hope, J. Bone Oncol., in press.

Sorted by citations

Items 101–200 of 236

Impact of ABC Transporters in Osteosarcoma and Ewing’s Sarcoma: Which Are Involved in Chemoresistance and Which Are Not?
Serra, M., Hattinger, C. M., Pasello, M., Casotti, C., Fantoni, L., Riganti, C., & Manara, M. C. (2021) · Cells · doi:10.3390/cells10092461 · Cited by 20
Sex differences in expression of immune elements emerge in children, young adults and mice with osteosarcoma.
Mills, L. J., Spector, L. G., Largaespada, D. A., & Williams, L. A. (2021) · Biology of Sex Differences · doi:10.1186/s13293-020-00347-y · Cited by 17
Microenvironment matters: insights from the FOSTER consortium on microenvironment-driven approaches to osteosarcoma therapy
Dutour, A., Pasello, M., Farrow, L., Amer, M. H., Entz‐Werlé, N., Nathrath, M., Scotlandi, K., Mittnacht, S., & Gomez‐Brouchet, A. (2025) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10257-3 · Cited by 21
Prognostic Significance of Programmed Death Ligand 1 Expression and Tumor-Infiltrating Lymphocytes in Axial Osteosarcoma
Liu, P., Xiao, Q., Zhou, B. R., Dai, Z., & Kang, Y. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.05.121 · Cited by 17
Low GNG12 Expression Predicts Adverse Outcomes: A Potential Therapeutic Target for Osteosarcoma
Yuan, J., Yuan, Z. K., Ye, A., Wu, T., Jia, J., Guo, J., Zhang, J., Li, T., & Cheng, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.758845 · Cited by 16
Bioinformatics analysis of the key genes in osteosarcoma metastasis and immune invasion
Liang, J., Chen, J., Hua, S., Qin, Z., Lu, J., & Lan, C. (2022) · Translational Pediatrics · doi:10.21037/tp-22-402 · Cited by 16
Comprehensive multi-omics analysis reveals m7G-related signature for evaluating prognosis and immunotherapy efficacy in osteosarcoma
Zhang, Y., Gan, W., Ru, N., Xue, Z., Chen, W., Chen, Z., Wang, H., & Zheng, X. (2023) · Journal of bone oncology · doi:10.1016/j.jbo.2023.100481 · Cited by 16
Evaluation of tumor-infiltrating lymphocytes in osteosarcomas of the jaws: a multicenter study
Alves, P. M., de Arruda, J. A. A., Arantes, D. A. C., Costa, S. F. D. S., de Souza, L. L., Pontes, H. A. R., Fonseca, F. P., Mesquita, R. A., Nonaka, C. F. W., Mendonça, E. F., et al. (2018) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-018-2499-6 · Cited by 16
Applying Osteosarcoma Immunology to Understand Disease Progression and Assess Immunotherapeutic Response
Pratt, H. G., Justin, E. M., & Lindsey, B. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43085-6_6 · Cited by 16
ANXA1 as a Prognostic and Immune Microenvironmental Marker for Gliomas Based on Transcriptomic Analysis and Experimental Validation
Lin, Z., Wen, M., Yu, E., Lin, X., Wang, H., Chen, J., Yao, C., Zhang, H., Ru, J., Wang, K., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.659080 · Cited by 16
BMPR2 expression level is correlated with low immune infiltration and predicts metastasis and poor survival in osteosarcoma
Cao, H., Quan, S., Zhang, L., Chen, Y., & Jiao, G. (2021) · Oncology Letters · doi:10.3892/ol.2021.12652 · Cited by 15
Identification of Epithelial–Mesenchymal Transition-Related Prognostic lncRNAs Biomarkers Associated With Melanoma Microenvironment
Xiao, B., Liu, L., Chen, Z., Li, A., Wang, P., Xiang, C., Zeng, Y., Li, H., & Xiao, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.679133 · Cited by 15
Osteosarcoma through the Lens of Bone Development, Signaling, and MicroenvironmentPreprint
Young, E. P., Marinoff, A. E., López-Fuentes, E., & Sweet-Cordero, A. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041635 · Cited by 14
The sEVs miR-487a/Notch2/GATA3 axis promotes osteosarcoma lung metastasis by inducing macrophage polarization toward the M2-subtype
Wang, P., Yang, L., Dong, J., Liu, W., Xie, F., Lu, Y., & Li, W. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03488-x · Cited by 14
Unveiling the Protective Role of Melatonin in Osteosarcoma: Current Knowledge and Limitations
Al-Ansari, N., Samuel, S. M., & Büsselberg, D. (2024) · Biomolecules · doi:10.3390/biom14020145 · Cited by 13
Click Pt(IV)-Carbohydrates Pro-Drugs for Treatment of Osteosarcoma
Moynihan, E., Bassi, G., Ruffini, A., Panseri, S., Montesi, M., Velasco‐Torrijos, T., & Montagner, D. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.795997 · Cited by 13
Exploration and Validation of a Novel Inflammatory Response-Associated Gene Signature to Predict Osteosarcoma Prognosis and Immune Infiltration
Fu, Y., He, G., Liu, Z., Wang, J., Zhang, Z., Bao, Q., Wen, J., Jin, Z., & Zhang, W. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s340477 · Cited by 13
Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma
Hattinger, C. M., Salaroglio, I. C., Fantoni, L., Godel, M., Casotti, C., Kopecka, J., Scotlandi, K., Ibrahim, T., Riganti, C., & Serra, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010799 · Cited by 14
Identification of two immune subtypes in osteosarcoma based on immune gene sets
Yang, M., Cao, Y., Wang, Z., Zhang, T., Hua, Y., & Cai, Z. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107799 · Cited by 13
Genetically Modified T-Cell Therapy for Osteosarcoma: Into the Roaring 2020s
DeRenzo, C., & Gottschalk, S. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-43032-0_10 · Cited by 12
Osteosarcoma: A Comprehensive Morphological and Molecular Review with Prognostic Implications
Motassime, A. E., Vitiello, R., Comodo, R. M., Capece, G., Bocchino, G., Bocchi, M. B., Maccauro, G., & Meschini, C. (2025) · Biology · doi:10.3390/biology14101407 · Cited by 16
Manganese(III) Phthalocyanine Complex Nanoparticle-Loaded Glucose Oxidase to Enhance Tumor Inhibition through Energy Metabolism and Macrophage Polarization
Liu, Z., Li, C., Cao, Y., Xu, X., Zhou, Z., Du, J., Yang, S., & Yang, H. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c01251 · Cited by 12
Immunotherapeutic Strategies in the Management of Osteosarcoma
Supra, R., & Agrawal, D. K. (2023) · Journal of Orthopaedics and Sports Medicine · doi:10.26502/josm.511500076 · Cited by 11
Single-cell transcriptional profiling in osteosarcoma and the effect of neoadjuvant chemotherapy on the tumor microenvironment
He, X., Que, L.-Y., Yang, F., Feng, Y., Ren, D., & Song, X. (2024) · Journal of bone oncology · doi:10.1016/j.jbo.2024.100604 · Cited by 11
3D Tumor-Engineered Model Replicating the Osteosarcoma Stem Cell Niche and In Vivo Tumor Complexity
Bassi, G., Rossi, A., Campodoni, E., Sandri, M., Sarogni, P., Fulle, S., Voliani, V., Panseri, S., & Montesi, M. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c02567 · Cited by 11
Heparin and Heparin-Based Drug Delivery Systems: Pleiotropic Molecular Effects at Multiple Drug Resistance of Osteosarcoma and Immune Cells
Тодосенко, Н. М., Yurova, K. A., Хазиахматова, О. Г., Malashchenko, V. V., Хлусов, И. А., & Litvinova, L. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102181 · Cited by 12
Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis
Тодосенко, Н. М., Хлусов, И. А., Yurova, K. A., Хазиахматова, О. Г., & Litvinova, L. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108993 · Cited by 13
TCF19 / CDKN2A Regulates Glycolysis and Macrophage M2 Polarization for Osteosarcoma Progression
Hu, X., Chen, W., Yang, K., Zhu, C., Li, Z., Zheng, D., & Geng, R. (2025) · The FASEB Journal · doi:10.1096/fj.202401343rrr · Cited by 10
Local administration of IL-12 with an HC vector results in local and metastatic tumor control in pediatric osteosarcoma
Zalacaín, M., Buñuales, M., Marrodán, L., Labiano, S., González-Huarriz, M., Martínez-Vélez, N., Laspidea, V., Puigdelloses, M., García-Moure, M., González-Aparicio, M., et al. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.11.003 · Cited by 9
Infiltration of LPAR5+ macrophages in osteosarcoma tumor microenvironment predicts better outcomes
He, Y., Zhou, H., Huang, X., Qu, Y., Wang, Y.-G., Pei, W., Zhang, R., Chen, S., & You, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.909932 · Cited by 10
Development of Novel Pt(IV)-Carbohydrate Derivatives as Targeted Anticancer Agents against Osteosarcoma
Moynihan, E., Panseri, S., Bassi, G., Rossi, A., Campodoni, E., Dempsey, E., Montesi, M., Velasco‐Torrijos, T., & Montagner, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076028 · Cited by 12
Bioinformatics Analysis and Structure of Gastric Cancer Prognosis Model Based on Lipid Metabolism and Immune Microenvironment
Chen, Y., Hongjun, Y., Yu, Q., Pang, J., Sheng, M., & Tang, W. (2022) · Genes · doi:10.3390/genes13091581 · Cited by 10
ADAM19 and TUBB1 Correlate with Tumor Infiltrating Immune Cells and Predicts Prognosis in Osteosarcoma
Xing, D., Wang, J., Gong, M., Xiong, Z., & Zhao, Y. (2022) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207325666220406112305 · Cited by 9
A CIC-related-epigenetic factors-based model associated with prediction, the tumor microenvironment and drug sensitivity in osteosarcoma
Yu, B., Geng, C., Wu, Z., Zhang, Z., Zhang, A., Yang, Z., Huang, J., Xiong, Y., Yang, H., & Chen, Z. (2024) · Scientific Reports · doi:10.1038/s41598-023-49770-2 · Cited by 9
Elucidating the mechanisms of action of parecoxib in the MG-63 osteosarcoma cell line
Lemos, S., Sampaio‐Marques, B., Ludovico, P., Gaivão, I., Palmeira, C., Martins, G., Peixoto, F., Pinto‐Leite, R., & Oliveira, P. A. (2020) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000901 · Cited by 9
Long non-coding RNA X-inactive specific transcript promotes osteosarcoma metastasis via modulating microRNA-758/Rab16
Liu, W., Long, Q., Zhang, L., Zeng, D., Hu, B., Zhang, W., Liu, S., Deng, S., & Chen, L. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-1032 · Cited by 9
Osteosarcoma
Tattersall, L., Davison, Z., & Gartland, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.62259-6 · Cited by 10
Digging Through the Complexities of Immunological Approaches in Emerging Osteosarcoma Therapeutics: A Comprehensive Narrative Review with Updated Clinical Trials
Sergi, C. M., Burnett, M., Jantuan, E., Hakoum, M., Beug, S. T., Leng, R. P., & Shen, F. (2025) · Biomedicines · doi:10.3390/biomedicines13030664 · Cited by 8
Up-regulation of Core 1 Beta 1, 3-Galactosyltransferase Suppresses Osteosarcoma Growth with Induction of IFN-γ Secretion and Proliferation of CD8+ T Cells
Chen, H., Cai, H., Tang, L., Cegang, F., Zhao, H., Wang, B., & Jia, S. (2022) · Current Cancer Drug Targets · doi:10.2174/1568009622666221010105701 · Cited by 8
Immune-based prognostic biomarkers associated with metastasis of osteosarcoma
Ma, T., Peng, C., Wu, D., Yang, S., Li, J., Zhang, C., & Gao, C. (2023) · General Physiology and Biophysics · doi:10.4149/gpb_2022050 · Cited by 8
Characterization of the Tumor Microenvironment in Jaw Osteosarcomas, towards Prognostic Markers and New Therapeutic Targets
Bertin, H., Peries, S., Amiaud, J., Acker, N. V., Perrot, B., Bouvier, C., Aubert, S., Marie, B., Larousserie, F., Pinieux, G. D. B. D., et al. (2023) · Cancers · doi:10.3390/cancers15041004 · Cited by 8
Vitamin B6 as a novel risk biomarker of fractured ankles
Li, Z., Zhang, S., Wan, L., Song, X., Yuan, D., Zhang, S., Wu, D., & Jiang, J. (2021) · Medicine · doi:10.1097/md.0000000000027442 · Cited by 8
Exploring the Tumor Microenvironment in Osteosarcoma: Driver of Resistance and Progression
Schmidt, A. A., Prasad, A., Huisman, A. R., Wakefield, M. R., & Fang, Y. (2025) · Cancers · doi:10.3390/cancers17193106 · Cited by 9
Engineering Osteoimmune Responses with Functionalized Orthopedic Implants for Post‐Operative Osteosarcoma Treatment
Dong, Y., Wang, L., Zhang, H., Li, M., Luo, Z. Y., Hu, Y., & Cai, C.-Y. (2025) · Advanced Science · doi:10.1002/advs.202512363 · Cited by 8
Identification of Gene as Predictive Biomarkers for the Occurrence and Recurrence of Osteosarcoma
Luo, Y., Lv, B., He, S., Zou, K., & Hu, K. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s312277 · Cited by 7
The smac mimetic LCL161 targets established pulmonary osteosarcoma metastases in mice
Harris, M. A., Shekhar, T. M., Miles, M. A., Cerra, C., & Hawkins, C. J. (2021) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10116-9 · Cited by 7
The Effect of miR-138 on the Function of Follicular Helper T Cells and the Differentiation of B Cells in Osteosarcoma
Wang, Z., Liang, J., Jiang, S., Zhao, G., Lu, J., & Jiang, B. (2021) · Computational and Mathematical Methods in Medicine · doi:10.1155/2021/2057782 · Cited by 7
Retracted
Oncolytic Viruses and Their Potential as a Therapeutic Opportunity in Osteosarcoma
Wedekind, M. F., & Cripe, T. P. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43085-6_5 · Cited by 7
Pyroptosis-Related Gene Signature Is a Novel Prognostic Biomarker for Sarcoma Patients
Wei, D., Lan, X., Huang, Z., Tang, Q., Wang, Z., Ma, Y., Wei, L., Wei, Q., Zhao, J., Shen, J., et al. (2021) · Disease Markers · doi:10.1155/2021/9919842 · Cited by 6
Oncogenic and immunological values of RBM34 in osteosarcoma and its pan-cancer analysis.
Zhang, W., He, R. L., Cao, W., Li, D., Zheng, Q., & Zhang, Y. (2023) · PubMed Central · Cited by 6
Machine learning-based selection of immune cell markers in osteosarcoma: prognostic determination and validation of CLK1 in disease progression
Zhang, N., Haizhen, Z., Zhang, R., & Li, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1468875 · Cited by 6
Analysis of scRNA-seq and bulk RNA-seq demonstrates the effects of EVI2B or CD361 on CD8 + T cells in osteosarcoma
Xie, T., Feng, W., He, M., Zhan, X., Liao, S., He, J., Qin, Z., Li, F., Xu, J., Liu, Y., et al. (2022) · Experimental Biology and Medicine · doi:10.1177/15353702221142607 · Cited by 7
Ewing sarcoma genomics and recent therapeutic advancements
Chavan, M., Dhakal, S., Singh, A., Rai, V., Arora, S., Mallipeddi, M. C., & Das, A. (2023) · Pediatric Hematology Oncology Journal · doi:10.1016/j.phoj.2023.02.001 · Cited by 6
Pediatric cancer—pathology and microenvironment influence: a perspective into osteosarcoma and non-osteogenic mesenchymal malignant neoplasms
Sergi, C. M. (2024) · Discover Oncology · doi:10.1007/s12672-024-01240-5 · Cited by 5
Delineating the nexus between gut-intratumoral microbiome and osteo-immune system in bone metastases
Kapoor, S., Gupta, M., Sapra, L., Kaur, T., & Srivastava, R. K. (2024) · Bone Reports · doi:10.1016/j.bonr.2024.101809 · Cited by 5
Osteosarcoma-Associated Immune Genes as Potential Immunotherapy and Prognosis Biomarkers
Yang, L., Long, Y., & Xiao, S. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10444-3 · Cited by 5
Development of a Novel Immune Infiltration-Related ceRNA Network and Prognostic Model for Sarcoma
Shi, D., Mu, S., Pu, F., Zhong, B., Hu, B., Liu, J., He, T., Zhang, Z., & Shao, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.652300 · Cited by 5
What role does GPR65 play in the progression of osteosarcoma? Its mechanism and clinical significance
Jin, Q., Liu, S., & Zhang, Z. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03216-5 · Cited by 5
Comprehensive Characterization of Prognostic Long Noncoding RNAs in Osteosarcoma
Gao, H., Guo, Y., Zhang, M., & Yi, Z. (2020) · BioMed Research International · doi:10.1155/2020/6725753 · Cited by 5
Global Characterization of Metabolic Genes Regulating Survival and Immune Infiltration in Osteosarcoma
Zhu, Z., Zhang, M., Wang, W., Zhang, P., Wang, Y., & Wang, L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.814843 · Cited by 5
Targeting the osteosarcoma immune microenvironment for improved immunotherapy and translational applications
Cai, J., Qiu, S., Sun, B., Ge, J., Yu, Z., & Wang, C. (2025) · Discover Oncology · doi:10.1007/s12672-025-04315-z · Cited by 5
Identification of molecular subtypes and prognostic model to reveal immune infiltration and predict prognosis based on immunogenic cell death-related genes in lung adenocarcinoma
Dong, Y., Yu, X. F., Song, H., Chen, Q., Zheng, B., Ji, X., Xu, M., Liu, J., Sun, X., Wang, Q., et al. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2300591 · Cited by 4
GBP1-CDK9-STAT3 signaling axis promotes osteosarcoma PD-L1 expression and immune escape
Jing, D., Chen, B., Liang, R., Li, F., Zhao, B., Pu, F., & Wu, W. (2025) · Neoplasia · doi:10.1016/j.neo.2025.101232 · Cited by 4
Decoding the function of cancer-associated fibroblasts in osteosarcoma: Molecular pathways, therapeutic approaches and prognostic significance
Hsu, C., Alkhathami, A. G., ahmed, T. A., Chandra, M., Mohammed, J. S., Malathi, H., Sah, K. K., Chauhan, A. S., iwadi, A., & Ali, A. F. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114612 · Cited by 4
Comprehensive Analysis of a ceRNA Network Identifies lncR‐C3orf35 Associated with Poor Prognosis in Osteosarcoma
Shi, Y., Ren, J., Zhuang, Z., Zhang, W., Wang, Z., Liu, Y., Li, J., Liang, T., He, R., & Wang, K. (2020) · BioMed Research International · doi:10.1155/2020/3178037 · Cited by 4
TREM2 as a Prognostic Biomarker for Osteosarcoma Microenvironment Remodeling
Shen, Z. Z., Chen, Z.-Y., Ji, Y., Jiang, H., Zhu, Z.-P., Yuan, H., Li, B., Xu, W., & Xiao, J. (2023) · Journal of Oncology · doi:10.1155/2023/3677789 · Cited by 3
Breaking down the tumor immune infiltration within pediatric sarcomas
Weil, R., & Loeb, D. M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1187289 · Cited by 4
The immune cell infiltration-associated molecular subtypes and gene signature predict prognosis for osteosarcoma patients
Liu, B., Liu, X., Wang, G., & Chen, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-55890-0 · Cited by 3
Modeling 3D Tumor Invasiveness to Modulate Macrophage Phenotype in a Human‐Based Hydrogel Platform
Monteiro, C. F., Almeida, C. R., Custódio, C. A., & Mano, J. F. (2024) · Macromolecular Bioscience · doi:10.1002/mabi.202400227 · Cited by 3
Development of an immune-related signature for predicting survival outcome and immunotherapy response in osteosarcoma
Wang, Q., Zhang, W., Guo, Y., Li, Y., & Fu, K. (2021) · Aging · doi:10.18632/aging.203671 · Cited by 3
Development of Personalized Signature Based on the Immune Landscape to Predict the Prognosis of Osteosarcoma and the Response to Immunotherapy and Targeted Therapy
Feng, X., Zhao, Z., Zhao, Y., Song, Z., Ma, Y., & Wang, W. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.783915 · Cited by 3
TNF-α orchestrates ADAM metallopeptidase with thrombospondin type 1 motif 2 upregulation and extracellular matrix remodeling through multimodal signaling in osteosarcoma cells
Aymaz, E. M., Alper, M., KALFA, Y., & KOCKAR, F. T. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11493-8 · Cited by 2
Construction of the prognostic enhancer RNA regulatory network in osteosarcoma
Yan, P., Li, Z., Xian, S., Wang, S., Fu, Q., Zhu, J., Yue, X., Zhang, X., Chen, S., Zhang, W., et al. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101499 · Cited by 2
Vitamin B12 as a novel risk biomarker of spinal fractures
Li, Z., Zheng, R., Xue, H., & Zhu, H. (2022) · Medicine · doi:10.1097/md.0000000000030796 · Cited by 1
Efficacy of Recombinant Human Endostatin plus Neoadjuvant Chemotherapy for Osteosarcoma and Its Influence on Serum VEGF and MMP-9 Levels
Sui, W., & Lin, G. (2023) · Journal of Oncology · doi:10.1155/2023/8161683 · Cited by 2
Immunotherapy of Osteosarcoma
Sorteberg, A. L., Ek, L., Lilienthal, I., & Herold, N. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_236-1 · Cited by 2
A Novel Defined Necroptosis-Related Genes Prognostic Signature for Predicting Prognosis and Treatment of Osteosarcoma
Zhao, S., Wang, T., Huang, F., Zhao, Q., Gong, D., Liu, J., Yi, C., Liang, S., Bian, E., Tian, D., et al. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10446-1 · Cited by 2
Identification and prognostic evaluation of differentially expressed long noncoding RNAs associated with immune infiltration in osteosarcoma
Wang, B., Wang, X., Du, X., Gao, S., Liang, B., & Yao, W. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27023 · Cited by 2
An immune-related eleven-RNA signature-drived risk score model for prognosis of osteosarcoma metastasis
Teng, J.-S., & Wang, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-54292-6 · Cited by 3
Evaluation of Indoleamine 2,3-Dioxygenase (IDO) Expression in Osteosarcoma: Insights From a 10-Year Retrospective Cohort
Farooq, A., Amin, A., Bashir, S., Fatima, M., Hassan, M. J., Sheikh, A., Tahseen, M., Sheikh, U., & Asghar, K. (2025) · OncoTargets and Therapy · doi:10.2147/ott.s494899 · Cited by 2
Screening and verification of prognostic lncRNA markers related to immune infiltration in the metastasis of osteosarcoma
He, C. H., Wang, X., Ni, L., Song, C., & Mai, W. (2022) · Translational Cancer Research · doi:10.21037/tcr-22-1926 · Cited by 2
Cancer stem cells and clonal evolution in bone sarcomas
Rodríguez, R., Hatina, J., Gambera, S., Menéndez, S. T., & García-Castro, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00010-4 · Cited by 1
Zoledronic acid enhances tumor growth and metastatic spread in a mouse model of jaw osteosarcoma
Nham, T., Guiho, R., Brion, R., Amiaud, J., Royer, B. B.-L., Gomez‐Brouchet, A., Rédiní, F., & Bertin, H. (2024) · Oral Diseases · doi:10.1111/odi.14897 · Cited by 1
Targeting heparanase/heparan sulfate proteoglycans by non‐anticoagulant heparins: Opportunities for innovative therapeutic approaches in sarcomas
Lanzi, C., Pasquali, S., & Cassinelli, G. (2024) · Proteoglycan Research · doi:10.1002/pgr2.70005 · Cited by 3
Exploration of research hotspots and evolutionary trends in osteosarcoma pulmonary metastasis: A comprehensive bibliometric analysis spanning five decades
Yu, C., Jiang, X., Wei, S., Zhou, C., Zhou, C., Wei, Y., & Su, Z. (2025) · Journal of Orthopaedics · doi:10.1016/j.jor.2025.03.053 · Cited by 1
Screening and identification Hub genes associated with immune cell infiltration and critical biomarkers in osteosarcoma
Song, X., Chen, S., Cheng, J., Li, H., Wu, R., Yan, M., Wang, M., Li, J., Jin, A., & Wang, W. (2025) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2025.102031 · Cited by 1
Immunotherapy of Osteosarcoma
Sorteberg, A. L., Ek, L., Lilienthal, I., & Herold, N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00769-8_236 · Cited by 1
LIG1 overexpression enhances DNA repair and immune escape leading to poor prognosis in osteosarcoma
Fu, W., Tang, G., Tang, Y., Yan, P., & Wang, Q. (2025) · European journal of medical research · doi:10.1186/s40001-025-03647-4 · Cited by 1
Decoding CTCs in osteosarcoma: the molecular journey from initial tumor to metastasis
Gangi, A. D., Morelli, M., Ipponi, E., Catena, F., Coccoli, L., Gaeta, R., Aretini, P., Menicagli, M., Franchi, A., Palmini, G., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-47094-5 · Cited by 1
Identification of a novel MYC target gene set signature for predicting the prognosis of osteosarcoma patients
Gong, D., Zhao, Q., Liu, J., Zhao, S., Yi, C., Lv, J., Yu, H., Bian, E., & Tian, D. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1169430 · Cited by 1
Osteosarcoma biomarker analysis and drug targeting prediction based on pyroptosis-related genes
Zhuang, Y., & Li, X. (2025) · Medicine · doi:10.1097/md.0000000000040240 · Cited by 1
Comprehensive analysis of ESCRT transcriptome-associated signatures and identification of the regulatory role of LMO7-AS1 in osteosarcoma
Zhao, S., Tian, D., Huang, F., Wang, L., Cheng, J., He, Z., Shen, Q., Liang, S., Gong, D., Liu, J., et al. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03659-4 · Cited by 1
Application of Macro-Synthetic-Fiber-Reinforced Sprayed Concrete for Primary Lining Support on Highway Tunnel Project in Bosnia and Herzegovina
Terzic, D. I. V. (2018) · Aspects in Mining & Mineral Science · doi:10.31031/amms.2018.01.000513
Expression of the Programmed Death Ligand (PDL-1) CD274 in Oral Squamous Cell Carcinomas
Kingsley, K. (2018) · Modern Research in Dentistry · doi:10.31031/mrd.2018.02.000526
Identification of Driver Genes and Key Pathways of Osteosarcoma Shows K-7174 As a Novel Anti-osteosarcoma Drug by Inhibiting VCAM1Preprint
Fu, Z., Yu, J., Liu, Y., Wu, B., Cheng, L., Zhou, P., & Zhu, D. (2020) · Research Square · doi:10.21203/rs.3.rs-113745/v1
Monitoring the Systemic Immune System to Understand and Improve the Efficacy of Immunotherapy for Metastatic Osteosarcoma
Markel, J. (2020) · doi:10.33915/etd.7770
Faculty Opinions recommendation of Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group.
Gaspar, N. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736286746.793579340
Editorial
Lohmueller, J. J., & Cascio, S. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2019.103967
Oncolytic adenovirus Delta-24- RGD engineered to express 4-1BBL or OX40L as therapeutic approach for diffuse intrinsic pontine gliomas
Laspidea, V. (2022) · Deposito Adademico Digital Universidad De Navarra (University of Navarra) · doi:10.15581/10171/65228
Data from Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at Diagnosis
Marchais, A., Costa, M. E. M. D., Job, B., Abbas, R., Drubay, D., Piperno-Neumann, S., Fromigué, O., Gomez‐Brouchet, A., Rédiní, F., Droit, R., et al. (2023) · doi:10.1158/0008-5472.c.6513441.v1

Authors: Heymann, M.-F., Lézot, F., & Heymann, D.
Affiliations: Inserm (FR)
Corresponding author: Heymann, Dominique
ORCID: Heymann, Marie-Françoise
Lézot, Frédéric
Heymann, Dominique
Venue: Cellular Immunology
Publisher: Elsevier BV
Published: 2019-09
Volume: 343
Issue: 1
Pages: 103711
ISSN: 0008-8749 (ISSN-L)
DOI: 10.1016/j.cellimm.2017.10.011
OpenAlex: W2766090242
Cited by: 233
References: 125
Citations by year: 2026: 11 · 2025: 22 · 2024: 33 · 2023: 33 · 2022: 33 · 2021: 42 · 2020: 34 · 2019: 14
FWCI: 2.94
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (am, 372 d)
Locations: Cellular Immunology (acceptedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
Funders: Bone Cancer Research Trust (144681)
Topics: Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords: osteosarcoma, tumor microenvironment, tumor immune infiltrate, T cells, macrophages, macrophage polarization, PD-1/PD-L1 pathway, immune evasion, mesenchymal stem cells, mast cells, B cells, lung metastasis, drug resistance, immunotherapy
MeSH terms: Animals, Bone Neoplasms, Humans, Macrophages, Osteosarcoma, Lymphocyte Subsets, Tumor Microenvironment, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks